Pneumococcal Vaccines Clinical Trial
Official title:
A Phase 4, Randomized, Open-Label Trial To Assess The Impact Of Prophylactic Antipyretic Medication On The Immunogenicity Of 13-Valent Pneumococcal Conjugate Vaccine Given With Routine Pediatric Vaccinations In Healthy Infants
The purposes of this study are assess the immunological response (measure the amount of antibodies, i.e. proteins that fight off germs) produced by children after they have been given the 13-valent pneumococcal vaccine (13vPnC) and INFANRIX hexa at 2, 3, 4 and 12 months of age when medications to prevent fever are given on the same day as the vaccination. Also to evaluate the safety of 13-valent pneumococcal conjugate vaccine (13vPnC) in children who receive medications to prevent fever on the day of vaccination.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01953510 -
Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam
|
Phase 2/Phase 3 | |
Completed |
NCT05540028 -
Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine
|
Phase 1 | |
Recruiting |
NCT05298800 -
Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23
|
Phase 4 | |
Active, not recruiting |
NCT06077656 -
Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine
|
Phase 2 | |
Active, not recruiting |
NCT06151288 -
Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT06000397 -
Reminder Emails to Improve Pneumococcal Vaccine Completion at 12 Months of Age
|
N/A | |
Completed |
NCT00574548 -
Study Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPS
|
Phase 3 | |
Not yet recruiting |
NCT06271681 -
Evaluation of PCV15 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans
|
Phase 4 | |
Active, not recruiting |
NCT05844423 -
Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants
|
Phase 2 | |
Completed |
NCT00824655 -
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Children
|
Phase 3 | |
Completed |
NCT01646398 -
A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older
|
Phase 3 | |
Completed |
NCT00464945 -
Wyeth Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants
|
Phase 3 | |
Completed |
NCT03893448 -
Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)
|
Phase 3 | |
Completed |
NCT05297578 -
Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults
|
Phase 2 | |
Completed |
NCT01964716 -
13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants.
|
Phase 3 | |
Completed |
NCT05266456 -
Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults
|
Phase 1/Phase 2 | |
Completed |
NCT01537185 -
Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults
|
Phase 1 | |
Recruiting |
NCT00999739 -
Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults
|
Phase 3 | |
Not yet recruiting |
NCT05721456 -
Evaluation of the Non-Inferiority of a 12-Valent Pneumococcal Conjugate Vaccine in Healthy Children in Brazil.
|
Phase 3 | |
Active, not recruiting |
NCT02012309 -
Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
|
N/A |